[1] |
Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699.
|
[2] |
Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology[J]. Pancreas, 2011, 40(3): 352-358.
|
[3] |
Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients[J]. Medicine, 2015, 94(15): e680.
|
[4] |
Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients[J]. Arthritis Rheumatol, 2015, 67(9): 2466-2475.
|
[5] |
Lin W, Zhang P, Chen H, et al. Circulating plasmablasts plasma cells: a potential biomarker for IgG4-related disease[J]. Arthritis Res Ther, 2017, 19(1): 25.
|
[6] |
Ito F, Kamekura R, Yamamoto M, et al. IL-10+ T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease[J]. Immunol Lett, 2019(207): 56-63.
|
[7] |
Touzani F, Pozdzik A. New insights into immune cells cross-talk during IgG4-related disease[J]. Clin Immunol, 2019(198): 1-10.
|
[8] |
纪宗斐,马玲瑛,姜林娣.IgG4相关性疾病(IgG4-RD)发病机制的研究进展[J].复旦学报(医学版),2019, 46(1): 114-118,142.
|
[9] |
章士正.IgG4相关疾病的影像表现[J].中华放射学杂志,2014, 48(11): 881-886.
|
[10] |
梁亮,曾蒙苏,纪元,等.IgG4相关性疾病腹部病变的少见及不典型影像表现[J].中华放射学杂志,2014, 48(11): 887-892.
|
[11] |
Zhao Z, Wang Y, Guan Z, et al. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases[J]. Clin Exp Rheumatol, 2016, 34(1): 119-125.
|
[12] |
Zen Y. The pathology of IgG4-related disease in the bile duct and pancreas[J]. Semin Liver Dis, 2016, 36(3): 242-256.
|
[13] |
Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192.
|
[14] |
Detlefsen S, Mortensen MB, Pless TK, et al. Laparoscopic and percutaneous core needle biopsy plays a central role for the diagnosis of autoimmune pancreatitis in a single-center study from Denmark[J]. Pancreas, 2015, 44(6): 845-858.
|
[15] |
Umehara H, Okazaki K, Nakamura T, et al. Current approach to the diagnosis of IgG4-related disease-combination of comprehensive diagnostic and organ-specific criteria[J]. Mod Rheumatol, 2017, 27(3): 381-391.
|
[16] |
Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria[J].J Gastroenterol, 2007, 42 Suppl 18:39-41.
|
[17] |
Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis[J]. J Gastroenterol, 2008, 43(6): 403-408.
|
[18] |
Chang MC, Liang PC, Jan IS, et al. Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort[J]. BMJ Open, 2014, 4(8): e005900
|
[19] |
Chang MC, Liang PC, Jan S, et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels[J]. Pancreatology, 2014, 14(5): 366-372.
|
[20] |
Okazaki K, Chari ST, Frulloni L, et al. International consensus for the treatment of autoimmune pancreatitis[J]. Pancreatology, 2017, 17(1): 1-6.
|